Article Data

  • Views 300
  • Dowloads 120

Meeting Abstracts

Open Access

Pain management and COVID-19

  • Giustino Varrassi1

1Paolo Procacci Foundation, Via Tacito 7, 00193 Roma, Italy

DOI: 10.22514/sv.2021.200 Vol.17,Issue S1,September 2021 pp.57-57

Submitted: 26 August 2021 Accepted: 06 September 2021

Published: 15 September 2021

*Corresponding Author(s): Giustino Varrassi E-mail: giuvarr@gmail.com

Abstract

The still present COVID-19 pandemic, lasting for over 1.5 years, has put the health care systems in a challenging situation. Prioritizing other aspects, pain patients have been practically abandoned, probably because Pain Medicine is not perceived as a priority for the patients. The organization of Pain Clinics and the cares for in-hospital pain management is reduced for quantity and quality [1].

This challenging situation has also been victim of some misinformation. One of them was diffused at the very beginning of the pandemic. The use of NSAIDs, and especially of ibuprofen, was accused to be responsible for an increased risk of potential infection by SARS-CoV [2]. The subtle pathophysiologic mechanism behind this was supposed to be the action of ibuprofen on the angiotensin-converting enzyme 2 (ACE2), also involved in the action of coronoviruses. The shocking theory had obvious consequences, especially for its diffusion in the media, but was rejected immediately after [3] and also reviewed by the same authors [4]. Immediately after, other authors have expressed their perplexities on the topic [5]. Then, all the connections between COVID-19 and NSAIDs were summarized in an extensive review article [6].

The one above is just one of the examples of the disastrous consequences of COVID-19 pandemics on the poor patients suffering for pain, both acute and chronic. Other connected problems were related to the organization of the pain clinics and the network for home care for suffering pain patients.

All these topics will be illustrated and summarized during the lecture. The congress will be an excellent occasion to also collect opinions and feedbacks of the attending Colleagues.


Cite and Share

Giustino Varrassi. Pain management and COVID-19. Signa Vitae. 2021. 17(S1);57-57.

References

[1] Puntillo F, Giglio M, Brienza N, Viswanath O, Urits I, Kaye AD, et al. Impact of COVID-19 pandemic on chronic pain management: Looking for the best way to deliver care. Best Practice & Research Clinical Anaesthesiology. 2020; 34: 529–537.

[2] Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine. 2020; 8: e21.

[3] Varrassi G. Warning against the Use of Anti-Inflammatory Medicines to Cure COVID-19: Building Castles in the Air. Advances in Therapy. 2020; 37: 1705–1707.

[4] Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Authors’ reply. Lancet Resp Med. 2020; 8: e32–e33.

[5] Pergolizzi JV, Varrassi G, Magnusson P, LeQuang JA, Leopoulou M, Paladini A, et al. The concern about ACE/ARB and COVID-19: Time to hold your horses! Journal of the American Pharmacists Association. 2020; 60: e88–e90.

[6] Pergolizzi JV Jr, Varrassi G, Magnusson P, LeQuang JA, Paladini A, Taylor R, et al. COVID-19 and NSAIDS: A Narrative Review of Knowns and Unknowns. Pain and Therapy. 2020; 9: 353–358.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top